Skip to main content
. 2021 Sep 16;6(38):25062–25075. doi: 10.1021/acsomega.1c04302

Table 2. Potency of Sulfonamide Tethered (Hetero)aryl ethylidenes at h-P2X2R, h-P2X4R, h-P2X5R, and h-P2X7R.

compound R-substitution h-P2X2 IC50 ± SEMa/% inhibition h-P2X4 IC50 ± SEMa/% inhibition h-P2X5 IC50 ± SEMa/% inhibition h-P2X7 IC50 ± SEMa/% inhibition
6a -H >50 (20%)b >50 (46%)b >50 (20%)b 4.21 ± 0.01
6b 2-F 1.91 ± 0.03 >50 (40%)b >50 (16%)b 2.48 ± 0.10
6c 3-Br >50 (0%)b >50 (24%)b >50 (0%)b 5.54 ± 0.05
6d 4-Cl >50 (15%)b >50 (18%)b >50 (42%)b >50 (48%)b
6e 4-Br 3.22 ± 0.05 >50 (0%)b >50 (10%)b >50 (34%)b
6f 4-I 3.52 ± 0.07 >50 (32%)b >50 (21%)b 10.01 ± 0.07
6g 4-OCH3 3.48 ± 0.04 >50 (45%)b >50 (26%)b 2.09 ± 0.13
6h 4-NH2 0.32 ± 0.01 >50 (34%)b >50 (10%)b 1.10 ± 0.21
7a -H 1.57 ± 0.01 >50 (24%)b >50 (29%)b >50 (45%)b
7b 3-CH3 1.80 ± 0.02 >50 (8%)b >50 (12%)b >50 (47%)b
7c 4-CH3 1.59 ± 0.01 3.89 ± 0.05 >50 (31%)b 8.94 ± 0.01
7d 5-CH3 2.03 ± 0.04 3.21 ± 0.01 >50 (46%)b 4.53 ± 0.11
7e 3-Cl 2.17 ± 0.02 1.61 ± 0.04 >50 (27%)b 1.70 ± 0.09
7f 5-Cl >50 (37%)b 4.03 ± 0.07 >50 (0%)b 1.16 ± 0.03
7g 5-NO2 >50 (26%)b 2.44 ± 0.10 >50 (19%)b 6.80 ± 0.21
Suramin   13.45 ± 0.11 5.64 ± 0.04 16.07 ± 0.5 33.21 ± 0.47
PPADS   1.40 ± 0.10 5.25 ± 0.30 7.01 ± 0.12 >50 (34%)b
RB-2   0.89 ± 0.41 ndc ndc 2.79 ± 0.22
a

n = 3 unless otherwise noted.

b

Percent inhibition at 50 μM test compound concentration.

c

nd, not determined.